Zuzana S.
- Country
- Slovakia
- Department
- 3500: Klinika hematológie a tranfúziológie
Research Overview
Data & Insights
Has run more than one trial at 46 of 110 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in treating Philadelphia Chromosome Positive Chronic Myelogenous Leukemia, with particular focus on newly diagnosed cases in chronic phase.
- CML Treatment Optimization
- Targeted Therapy Approaches
- Adult Leukemia Management
Dedicated to advancing therapeutic options for patients with chronic myeloid leukemia through comparative assessment of novel treatment approaches.
Drug Tolerability Studies
Focuses on evaluating the tolerability profiles of tyrosine kinase inhibitors in leukemia treatment, with emphasis on comparing newer therapeutic agents against established treatments.
- Adverse Event Assessment
- Treatment Duration Analysis
- Safety Profile Evaluation
Investigates long-term treatment sustainability and adverse event patterns in chronic phase CML patients.
Clinical Innovation
Explores innovative therapeutic approaches in hematologic malignancies, particularly focusing on oral targeted therapies for chronic myeloid conditions.
- Novel Drug Development
- Treatment Comparison Studies
- Adult Patient Care
Contributes to the advancement of therapeutic options for adult patients with Philadelphia chromosome-positive leukemia.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.